SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-200072
Filing Date
2019-07-23
Accepted
2019-07-23 16:51:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d779555ds3.htm S-3 314325
2 EX-4.3 d779555dex43.htm EX-4.3 301195
3 EX-4.5 d779555dex45.htm EX-4.5 103878
4 EX-4.6 d779555dex46.htm EX-4.6 105182
5 EX-4.7 d779555dex47.htm EX-4.7 94381
6 EX-5.1 d779555dex51.htm EX-5.1 25383
7 EX-23.1 d779555dex231.htm EX-23.1 1666
8 GRAPHIC g779555g43i93.jpg GRAPHIC 9275
9 GRAPHIC g779555g97m83.jpg GRAPHIC 16028
  Complete submission text file 0001193125-19-200072.txt   982210
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232771 | Film No.: 19968244
SIC: 2834 Pharmaceutical Preparations